5 mg dispersible/ chewable tablets – where 2 mg dispersible/ chewable tablets are not marketed and 5 mg dispersible/ chewable tablets are the lowest marketed strength :< It should be noted that with the currently available Lamictal 5 mg dispersible/chewable tablet strength, it is not possible to accurately initiate lamotrigine therapy using the recommended dosing guidelines in paediatric patients weighing less than 17 kg. >